Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Mounjaro is administered once weekly and was initially approved for the management of type 2 diabetes
In this scenario, patients currently using compounded semaglutide would need to transition to brand-name Ozempic or Wegovy, switch to a different GLP-1 agonist (tirzepatide, liraglutide), or discontinue treatment
(PubMed) Mills JL, Scott JM, Kirke PN, et al
In 12 states there is coverage in one market, six states have coverage in two markets, five states have coverage in three markets, and in just three states there is coverage in all four markets
US$ 29.04
US$ 21.24
US$ 27.29
US$ 25.42
